Ortega-Atienza Sara, Green Samantha E, Zhitkovich Anatoly
Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.
Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.
Toxicol Appl Pharmacol. 2015 Jul 15;286(2):135-41. doi: 10.1016/j.taap.2015.03.018. Epub 2015 Mar 24.
Formaldehyde (FA) is a human carcinogen with numerous sources of environmental and occupational exposures. This reactive aldehyde is also produced endogenously during metabolism of drugs and other processes. DNA-protein crosslinks (DPCs) are considered to be the main genotoxic lesions for FA. Accumulating evidence suggests that DPC repair in high eukaryotes involves proteolysis of crosslinked proteins. Here, we examined a role of the main cellular proteolytic machinery proteasomes in toxic responses of human lung cells to low FA doses. We found that transient inhibition of proteasome activity increased cytotoxicity and diminished clonogenic viability of FA-treated cells. Proteasome inactivation exacerbated suppressive effects of FA on DNA replication and increased the levels of the genotoxic stress marker γ-H2AX in normal human cells. A transient loss of proteasome activity in FA-exposed cells also caused delayed perturbations of cell cycle, which included G2 arrest and a depletion of S-phase populations at FA doses that had no effects in control cells. Proteasome activity diminished p53-Ser15 phosphorylation but was important for FA-induced CHK1 phosphorylation, which is a biochemical marker of DPC proteolysis in replicating cells. Unlike FA, proteasome inhibition had no effect on cell survival and CHK1 phosphorylation by the non-DPC replication stressor hydroxyurea. Overall, we obtained evidence for the importance of proteasomes in protection of human cells against biologically relevant doses of FA. Biochemically, our findings indicate the involvement of proteasomes in proteolytic repair of DPC, which removes replication blockage by these highly bulky lesions.
甲醛(FA)是一种人类致癌物,存在多种环境和职业暴露源。这种活性醛在药物代谢及其他过程中也会内源性产生。DNA-蛋白质交联(DPCs)被认为是FA的主要遗传毒性损伤。越来越多的证据表明,高等真核生物中的DPC修复涉及交联蛋白的蛋白水解。在此,我们研究了细胞主要蛋白水解机制蛋白酶体在人肺细胞对低剂量FA毒性反应中的作用。我们发现,短暂抑制蛋白酶体活性会增加细胞毒性,并降低FA处理细胞的克隆生存能力。蛋白酶体失活加剧了FA对DNA复制的抑制作用,并增加了正常人细胞中遗传毒性应激标志物γ-H2AX的水平。FA暴露细胞中蛋白酶体活性的短暂丧失还导致细胞周期的延迟扰动,包括在FA剂量下出现G2期阻滞和S期细胞群体减少,而这些剂量对对照细胞没有影响。蛋白酶体活性降低了p53-Ser15磷酸化,但对FA诱导的CHK1磷酸化很重要,CHK1磷酸化是复制细胞中DPC蛋白水解的生化标志物。与FA不同,蛋白酶体抑制对非DPC复制应激源羟基脲诱导的细胞存活和CHK1磷酸化没有影响。总体而言,我们获得了证据,证明蛋白酶体在保护人类细胞免受生物学相关剂量的FA影响方面具有重要作用。从生化角度来看,我们的研究结果表明蛋白酶体参与了DPC的蛋白水解修复,从而消除了这些高度庞大的损伤对复制的阻碍。